[go: up one dir, main page]

CN1326849C - Hexahydro-phthalmide compound, its preparation and use thereof - Google Patents

Hexahydro-phthalmide compound, its preparation and use thereof Download PDF

Info

Publication number
CN1326849C
CN1326849C CNB2005100151680A CN200510015168A CN1326849C CN 1326849 C CN1326849 C CN 1326849C CN B2005100151680 A CNB2005100151680 A CN B2005100151680A CN 200510015168 A CN200510015168 A CN 200510015168A CN 1326849 C CN1326849 C CN 1326849C
Authority
CN
China
Prior art keywords
compound
independently selected
atom
preparation
structural formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CNB2005100151680A
Other languages
Chinese (zh)
Other versions
CN1746166A (en
Inventor
席真
班树荣
陈文彬
李康
施捷
王勇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nankai University
Original Assignee
Nankai University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nankai University filed Critical Nankai University
Priority to CNB2005100151680A priority Critical patent/CN1326849C/en
Publication of CN1746166A publication Critical patent/CN1746166A/en
Application granted granted Critical
Publication of CN1326849C publication Critical patent/CN1326849C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

本发明涉及一种酰亚胺类化合物及其制备方法,可用于制备杀菌剂,其为结构式I所示的酰亚胺类化合物及其非毒性盐:在惰性溶剂水、1,4-二氧六环、二氯甲烷、氯仿、四氢呋喃、甲苯、三甲苯中的单一溶剂或混合溶剂存在下,反应温度保持在80-150℃,将结构式II所示的化合物与结构式III所示的化合物反应得到结构式I所示的化合物,其中:R1独立地选自羟基、巯基、烷基、SCN、N3、芳基、杂芳基、稠杂芳基;R2、R3均独立地选自H原子、羟基、巯基、卤原子、SCN、烷基、烷氧基、N3、芳基、杂芳基、稠杂芳基;X为N原子或CH。本发明化合物结构合理,制备方法简便,用于制备杀菌剂。

Figure 200510015168

The invention relates to an imide compound and a preparation method thereof, which can be used to prepare a bactericide, which is an imide compound represented by structural formula I and a non-toxic salt thereof: in the inert solvent water, 1,4-diox In the presence of a single solvent or a mixed solvent in hexacyclic, dichloromethane, chloroform, tetrahydrofuran, toluene, and trimethylbenzene, the reaction temperature is kept at 80-150 ° C, and the compound shown in the structural formula II is reacted with the compound shown in the structural formula III to obtain The compound shown in structural formula I, wherein: R 1 is independently selected from hydroxyl, mercapto, alkyl, SCN, N 3 , aryl, heteroaryl, fused heteroaryl; R 2 and R 3 are independently selected from H atom, hydroxyl, mercapto, halogen, SCN, alkyl, alkoxy, N 3 , aryl, heteroaryl, fused heteroaryl; X is N atom or CH. The compound of the invention has a reasonable structure and a simple and convenient preparation method, and is used for the preparation of fungicides.

Figure 200510015168

Description

六氢酞酰亚胺类化合物及其制备和用途Hexahydrophthalimide compounds and their preparation and use

技术领域technical field

本发明涉及酰亚胺类化合物,特别是应用于制备杀菌剂的一种酰亚胺类化合物,以及其制备方法。The invention relates to an imide compound, especially an imide compound used in the preparation of a fungicide, and a preparation method thereof.

背景技术Background technique

酰亚胺类化合物作为杀菌剂已经有很多报导,并且商品化了一些,例如:克菌丹(captan)、灭菌丹(folpet)、四氯丹(Captafol)、依普同.(Iprodione)和免克宁(Vinclozolin)等:There are many reports of imide compounds as bactericides, and some are commercialized, such as: captan (captan), folpet (folpet), tetrachlordane (Captafol), Yipu Tong. (Iprodione) and Vinclozolin, etc.:

但是其中一些杀菌剂对环境不友好,对人有毒副作用。而且长期使用会使菌株产生明显的抗性。因此设计合成高效、低毒、广谱、高选择性及低残留和低抗性杀菌剂是当前农药研究中迫在眉睫的问题。But some of these fungicides are not friendly to the environment and have toxic side effects on people. And long-term use will cause the strain to develop obvious resistance. Therefore, designing and synthesizing fungicides with high efficiency, low toxicity, broad spectrum, high selectivity, low residue and low resistance is an urgent problem in the current pesticide research.

发明内容Contents of the invention

本发明提供一种酰亚胺类化合物,具有杀菌活性,其可应用于制备杀菌剂。The invention provides an imide compound, which has bactericidal activity and can be applied to the preparation of bactericides.

本发明解决其技术问题所采用的技术方案是:The technical solution adopted by the present invention to solve its technical problems is:

本发明提供一种酰亚胺类化合物是结构式(I)表示的化合物及其非毒性盐:The invention provides a kind of imide compound is the compound represented by structural formula (I) and non-toxic salt thereof:

其中,R1独立地选自羟基、巯基、烷基、SCN、N3、芳基、杂芳基、稠杂芳基;R2、R3均独立地选自H原子、羟基、巯基、卤原子、SCN、烷基、烷氧基、N3、芳基、杂芳基、稠杂芳基;X为N原子或CH。Wherein, R 1 is independently selected from hydroxyl, mercapto, alkyl, SCN, N 3 , aryl, heteroaryl, fused heteroaryl; R 2 and R 3 are independently selected from H atom, hydroxyl, mercapto, halogen atom, SCN, alkyl, alkoxy, N 3 , aryl, heteroaryl, fused heteroaryl; X is N atom or CH.

结构式(I)表示的酰亚胺类化合物及其非毒性盐选自:The imide compounds represented by structural formula (I) and their non-toxic salts are selected from:

N-(4,6-双甲基嘧啶-2-基)-1,2,3,4,5,6-六氢酞酰亚胺(I-1)N-(4,6-bismethylpyrimidin-2-yl)-1,2,3,4,5,6-hexahydrophthalimide (I-1)

N-(4-氯-6-甲基嘧啶-2-基)-1,2,3,4,5,6-六氢酞酰亚胺(I-2)N-(4-chloro-6-methylpyrimidin-2-yl)-1,2,3,4,5,6-hexahydrophthalimide (I-2)

N-(4-甲基嘧啶-2-基)-1,2,3,4,5,6-六氢酞酰亚胺(I-3)N-(4-methylpyrimidin-2-yl)-1,2,3,4,5,6-hexahydrophthalimide (I-3)

N-(6-甲基吡啶-2-基)-1,2,3,4,5,6-六氢酞酰亚胺(I-4)N-(6-methylpyridin-2-yl)-1,2,3,4,5,6-hexahydrophthalimide (I-4)

结构式(I)表示的酰亚胺类化合物的制备方法:在惰性溶剂水、1,4-二氧六环、二氯甲烷、氯仿、四氢呋喃、甲苯、三甲苯中的单一溶剂或混合溶剂存在下,反应温度保持在80-150℃,将结构(II)所示的化合物与结构式(III)所示的化合物反应,得到结构式(I)所示的化合物,The preparation method of the imide compound represented by structural formula (I): in the presence of a single solvent or a mixed solvent in inert solvent water, 1,4-dioxane, methylene chloride, chloroform, tetrahydrofuran, toluene, trimethylbenzene , the reaction temperature is maintained at 80-150 ° C, the compound shown in the structure (II) is reacted with the compound shown in the structural formula (III), to obtain the compound shown in the structural formula (I),

Figure C20051001516800041
Figure C20051001516800041

其中:R1独立地选自羟基、巯基、烷基、SCN、N3、芳基、杂芳基、稠杂芳基;R2、R3均独立地选自H原子、羟基、巯基、卤原子、SCN、烷基、烷氧基、N3、芳基、杂芳基、稠杂芳基;X为N原子或CH。Wherein: R 1 is independently selected from hydroxyl, mercapto, alkyl, SCN, N 3 , aryl, heteroaryl, fused heteroaryl; R 2 and R 3 are independently selected from H atom, hydroxyl, mercapto, halogen atom, SCN, alkyl, alkoxy, N 3 , aryl, heteroaryl, fused heteroaryl; X is N atom or CH.

本发明所提供通式(I)药学可接受的盐也是属于本发明范围之内。The pharmaceutically acceptable salts of general formula (I) provided by the present invention also fall within the scope of the present invention.

本发明化合物可以是晶态物质或溶剂化物质(比如水合物),两种状态的物质都归属于本发明范围之内,溶剂化方法在现有技术中是广为所知的,不再赘述。The compound of the present invention can be a crystalline substance or a solvated substance (such as a hydrate), and the substances in both states are within the scope of the present invention. The solvation method is widely known in the prior art and will not be repeated here. .

杀菌活性Bactericidal activity

为明确该系列化合物对多种植物病原菌的抗菌谱及其抑菌活性,本发明人对该系列化合物进行了室内抑菌测定,方法和结果如下:In order to clarify the antibacterial spectrum and bacteriostatic activity of this series of compounds to various plant pathogenic bacteria, the inventors carried out indoor bacteriostatic determination of this series of compounds. The method and results are as follows:

采用含药介质法。用万分之一天平分别称取药剂。将化合物分别称取5mg,用0.1mL丙酮溶解,再加吐温80稳定,然后用定量无菌蒸馏水配制成一定浓度250μg/mL稀释液,取4mL化合物稀释液放入灭菌的小三角瓶内,加36mL PDA培养基(浓度相应稀释10倍)混合均匀后,均等倒入3个灭菌平皿中。培养基凝固后接入直径d为5mm已活化的菌片,以培养基中不加药只加丙酮、吐温80稀释液接菌片为空白对照。每个处理重复3次。接菌完毕后,将平皿放入25℃恒温培养箱内,培养48小时测定菌落半径增加值,计算抑菌率(表1)。The drug-containing medium method is used. Weigh the medicaments with a ten-thousandth balance. Weigh 5 mg of the compound, dissolve it with 0.1 mL of acetone, add Tween 80 to stabilize it, then prepare a dilution solution with a certain concentration of 250 μg/mL with quantitative sterile distilled water, and take 4 mL of the compound dilution solution into a sterilized small Erlenmeyer flask , add 36mL PDA culture medium (the concentration is diluted 10 times accordingly), after mixing evenly, pour it into 3 sterilized plates equally. After the culture medium was solidified, the activated bacteria slices with a diameter d of 5 mm were inserted, and the bacteria slices inoculated with acetone and Tween 80 dilution were used as the blank control. Each treatment was repeated 3 times. After inoculation, put the plate into a constant temperature incubator at 25°C, cultivate for 48 hours, measure the increase in colony radius, and calculate the antibacterial rate (Table 1).

表1杀菌活性结果Table 1 Bactericidal activity results

编号serial number 抑制率 Inhibition rate 黄瓜立枯病Cucumber blight 黄瓜枯萎病cucumber wilt 番茄灰霉病 Tomato Botrytis 番茄叶霉病 tomato leaf mold 莴笋菌核病 Sclerotinia lettuce 辣椒疫病 pepper blight 苹果轮纹病 apple ring disease I-1 I-1 1 1 - - 2 2 1 1 - - 1 1 3 3 I-2 I-2 - - - - - - - - - - - - - -

  I-3 I-3    - -    - -   - -   1 1   1 1    1 1    2 2   I-4 I-4    3 3    1 1   2 2   3 3   - -    5 5    3 3

注:抑制率=0~20%时用1表示;抑制率=20~40%时用2表示;抑制率=40~60%时用3表示;抑制率=60~80%时用4表示;抑制率=80~100%时用5表示;-表示是负抑制率或未测。Note: Inhibition rate = 0-20% is represented by 1; inhibition rate = 20-40% is represented by 2; inhibition rate = 40-60% is represented by 3; inhibition rate = 60-80% is represented by 4; Inhibition rate = 80-100% is represented by 5; - indicates negative inhibition rate or not tested.

在对上述供试样品的生物活性测试中,结果发现该类化合物有良好的杀菌活性和杀菌谱。In the biological activity test of the above-mentioned test samples, it was found that this type of compound has good bactericidal activity and bactericidal spectrum.

本发明的有益效果是,化合物结构合理,采用的原料范围广泛,制备方法简便,合成工艺成本低,具有良好的杀菌活性和杀菌谱,产品符合环境友好和绿色化学的要求。The invention has the beneficial effects of reasonable compound structure, wide range of raw materials, simple preparation method, low synthesis process cost, good bactericidal activity and bactericidal spectrum, and the product meets the requirements of environmental friendliness and green chemistry.

附图说明Description of drawings

无附图no drawings

具体实施方式Detailed ways

本发明人经过大量研究,发现酰亚胺类化合物(I)具有良好的生物活性,可以直接用作药物或杀菌剂使用,或者可以作为有用药物或杀菌剂的中间体。After a lot of research, the inventors found that the imide compound (I) has good biological activity and can be directly used as a medicine or a fungicide, or as an intermediate of a useful medicine or a fungicide.

其中,R1独立地选自羟基、巯基、烷基、SCN、N3、芳基、杂芳基、稠杂芳基;R2、R3均独立地选自H原子、羟基、巯基、卤原子、SCN、烷基、烷氧基、N3、芳基、杂芳基、稠杂芳基;X为N原子或CH。Wherein, R 1 is independently selected from hydroxyl, mercapto, alkyl, SCN, N 3 , aryl, heteroaryl, fused heteroaryl; R 2 and R 3 are independently selected from H atom, hydroxyl, mercapto, halogen atom, SCN, alkyl, alkoxy, N 3 , aryl, heteroaryl, fused heteroaryl; X is N atom or CH.

为了达到合成目的,本发明人采取了反应流程1所示的方法。In order to achieve the purpose of synthesis, the inventors adopted the method shown in Reaction Scheme 1.

反应流程1Reaction scheme 1

在反应流程1中,R1独立地选自羟基、巯基、烷基、SCN、N3、芳基、杂芳基、稠杂芳基;R2、R3均独立地选自H原子、羟基、巯基、卤原子、SCN、烷基、烷氧基、N3、芳基、杂芳基、稠杂芳基;X为N原子或CH。In Reaction Scheme 1, R 1 is independently selected from hydroxyl, mercapto, alkyl, SCN, N 3 , aryl, heteroaryl, fused heteroaryl; R 2 and R 3 are independently selected from H atom, hydroxyl , mercapto, halogen atom, SCN, alkyl, alkoxy, N 3 , aryl, heteroaryl, condensed heteroaryl; X is N atom or CH.

在反应流程1中,所有反应的溶剂均可为水、1,4-二氧六环、二氯甲烷、氯仿、四氢呋喃、甲苯、三甲苯中的单一溶剂或混合溶剂,反应温度保持在80℃-150℃。In the reaction scheme 1, the solvent for all reactions can be a single solvent or a mixed solvent in water, 1,4-dioxane, methylene chloride, chloroform, tetrahydrofuran, toluene, and mesitylene, and the reaction temperature is kept at 80°C -150°C.

下面通过实施例对本发明进行详述,但本发明并不限于这些实施例,实施例中未提到的试剂从市面购得并以原样应用。The present invention will be described in detail through examples below, but the present invention is not limited to these examples, and the reagents not mentioned in the examples are purchased from the market and used as they are.

实施例1:N-(4,6-双甲基嘧啶-2-基)-1,2,3,4,5,6-六氢酞酰亚胺(I-1)的制备称量1,2,3,4,5,6-六氢苯酐152mg(1mmol)置于25mL圆底烧瓶中,加入10mL氯仿,再向其中加入123mg 2-氨基-4,6-双甲基嘧啶(1mmol)。反应温度保持在80℃。搅拌12小时,脱溶剂后柱层析(40g硅胶H,2%CH3OH/CH2Cl2洗脱)分得白色固体172mg。产率62%。其理化数据如下:[1H]NMR(400MHz,CDCl3):δ/ppm;7.055(s,1H,H-pyrimidine),3.060-3.037(t,J1=4.381Hz,J2=4.578Hz,2H,2CH),2.517(s,6H,2CH3),1.919(br.m,4H,2CH2),1.533-1.478(m,4H,2CH2).Mp.182-183℃。Example 1: Preparation of N-(4,6-bismethylpyrimidin-2-yl)-1,2,3,4,5,6-hexahydrophthalimide (I-1) Weighing 1, 152 mg (1 mmol) of 2,3,4,5,6-hexahydrophthalic anhydride was placed in a 25 mL round bottom flask, 10 mL of chloroform was added, and 123 mg of 2-amino-4,6-bismethylpyrimidine (1 mmol) was added thereto. The reaction temperature was maintained at 80°C. After stirring for 12 hours, column chromatography (40 g of silica gel H, eluted with 2% CH 3 OH/CH 2 Cl 2 ) after desolventization gave 172 mg of white solid. Yield 62%. Its physical and chemical data are as follows: [ 1 H]NMR (400MHz, CDCl 3 ): δ/ppm; 7.055(s, 1H, H-pyrimidine), 3.060-3.037(t, J 1 =4.381Hz, J 2 =4.578Hz, 2H, 2CH), 2.517 (s, 6H, 2CH 3 ), 1.919 (br.m, 4H, 2CH 2 ), 1.533-1.478 (m, 4H, 2CH 2 ). Mp. 182-183°C.

实施例2:N-(6-甲基吡啶-2-基)-1,2,3,4,5,6-六氢酞酰亚胺(I-4)的制备称量3,4,5,6-四氢苯酐152mg(1mmol)置于25mL圆底烧瓶中,加入10mL三甲苯,再向其中加入108mg 2-氨基-6-甲基吡啶(1mmol)。反应温度保持在150℃。搅拌10小时,脱溶剂后柱层析(40g硅胶H,2%CH3OH/CH2Cl2洗脱)分得白色固体177mg。产率73%。其理化数据如下:[1H]NMR(400MHz,CDCl3):δ/ppm;7.703-7.664(t,J1=7.750Hz,J2=7.731Hz,1H,Py),7.172-7.153(d,J=7.667Hz,1H,Py),7.018-6.998(d,J=7.787Hz,1H,Py),3.033-3.011(m,2H,2CH),2.545(s,3H,CH3),1.885(br.s,4H,2CH2),1.478-1.471(m,4H,2CH2).Mp.92-94℃。Example 2: Preparation of N-(6-methylpyridin-2-yl)-1,2,3,4,5,6-hexahydrophthalimide (I-4) Weigh 3,4,5 152 mg (1 mmol) of 6-tetrahydrophthalic anhydride was placed in a 25 mL round bottom flask, 10 mL of trimethylbenzene was added, and 108 mg of 2-amino-6-methylpyridine (1 mmol) was added thereto. The reaction temperature was maintained at 150°C. After stirring for 10 hours, column chromatography (40 g of silica gel H, eluted with 2% CH 3 OH/CH 2 Cl 2 ) after desolventization gave 177 mg of white solid. Yield 73%. Its physical and chemical data are as follows: [ 1 H]NMR (400MHz, CDCl 3 ): δ/ppm; 7.703-7.664(t, J 1 =7.750Hz, J 2 =7.731Hz, 1H, Py), 7.172-7.153(d, J=7.667Hz, 1H, Py), 7.018-6.998(d, J=7.787Hz, 1H, Py), 3.033-3.011(m, 2H, 2CH), 2.545(s, 3H, CH3 ), 1.885(br .s, 4H, 2CH 2 ), 1.478-1.471 (m, 4H, 2CH 2 ). Mp. 92-94°C.

实施例3:反应温度保持在110℃,加入10mL氯仿改变为加入10mL甲苯,其他反应条件同实施例1,产率67%,产物理化数据同实施例1。Example 3: The reaction temperature was maintained at 110° C., and 10 mL of chloroform was added instead of 10 mL of toluene. The other reaction conditions were the same as in Example 1, the yield was 67%, and the physical and chemical data of the product were the same as in Example 1.

实施例4:反应温度保持在120℃,加入10mL三甲苯改变为加入7mL三甲苯和3mL氯仿,其他反应条件同实施例2,产率75%,产物理化数据同实施例2。Example 4: The reaction temperature was maintained at 120° C., and 10 mL of trimethylbenzene was added instead of 7 mL of trimethylbenzene and 3 mL of chloroform. The other reaction conditions were the same as in Example 2, the yield was 75%, and the physical and chemical data were the same as in Example 2.

按照实例1只要改变化合物(II)的种类即可制备化合物(I)。当(II)是2-氨基-4-氯-6-甲基嘧啶时生成N-(4-氯-6-甲基嘧啶-2-基)-1,2,3,4,5,6-六氢酞酰亚胺(I-2);当(II)是2-氨基-4-甲基嘧啶时生成N-(4-甲基嘧啶-2-基)-1,2,3,4,5,6-六氢酞酰亚胺(I-3)。其它化合物的理化数据:Compound (I) can be prepared by changing the type of compound (II) according to Example 1. When (II) is 2-amino-4-chloro-6-methylpyrimidine, N-(4-chloro-6-methylpyrimidin-2-yl)-1,2,3,4,5,6- Hexahydrophthalimide (I-2); When (II) is 2-amino-4-methylpyrimidine, generate N-(4-methylpyrimidin-2-yl)-1,2,3,4, 5,6-Hexahydrophthalimide (I-3). Physicochemical data of other compounds:

N-(4-氯-6-甲基嘧啶-2-基)-1,2,3,4,5,6-六氢酞酰亚胺(I-2)白色固体.[1H]NMR(400MHz,CDCl3):δ/ppm;7.247(s,1H,pyrimidine),3.055-3.033(m,2H,2CH),2.555(s,3H,CH3),1.894(br.s,4H,2CH2),1.490-1.478(m,4H,2CH2).Yield=50%.Mp.100-107℃。N-(4-chloro-6-methylpyrimidin-2-yl)-1,2,3,4,5,6-hexahydrophthalimide (I-2) white solid. [ 1 H]NMR ( 400MHz, CDCl 3 ): δ/ppm; 7.247(s, 1H, pyrimidine), 3.055-3.033(m, 2H, 2CH), 2.555(s, 3H, CH 3 ), 1.894(br.s, 4H, 2CH 2 ), 1.490-1.478 (m, 4H, 2CH 2 ). Yield = 50%. Mp. 100-107°C.

N-(4-甲基嘧啶-2-基)-1,2,3,4,5,6-六氢酞酰亚胺(I-3)白色固体[1H]NMR(400MHz,CDCl3):δ/ppm;8.686-8.673(d,J=5.073Hz,1H,Pyrimidine),7.203-7.191(d,J=5.093Hz,1H,pyrimidine),3.072--3.050m,2H,2CH),2.579(s,3H,CH3),1.913(br.s,4H,2CH2),1.503--1.451(m,4H,2CH2).Yield=48%.Mp.176-178℃。N-(4-methylpyrimidin-2-yl)-1,2,3,4,5,6-hexahydrophthalimide (I-3) white solid [ 1 H]NMR (400MHz, CDCl 3 ) : δ/ppm; 8.686-8.673 (d, J=5.073Hz, 1H, pyrimidine), 7.203-7.191 (d, J=5.093Hz, 1H, pyrimidine), 3.072--3.050m, 2H, 2CH), 2.579 ( s, 3H, CH 3 ), 1.913 (br.s, 4H, 2CH 2 ), 1.503--1.451 (m, 4H, 2CH 2 ). Yield = 48%. Mp. 176-178°C.

以上所述,仅是本发明的较佳实施例,并非对本发明作任何形式上的限制,凡是依据本发明的技术实质对以上实施例所作的任何简单修改、等同变化与修饰,均仍属于本发明技术方案的范围内。The above are only preferred embodiments of the present invention, and are not intended to limit the present invention in any form. Any simple modifications, equivalent changes and modifications made to the above embodiments according to the technical essence of the present invention still belong to the present invention. within the scope of the technical solution of the invention.

Claims (4)

1、一种酰亚胺类化合物,其特征在于:其结构为结构式I表示的化合物:1. An imide compound, characterized in that: its structure is a compound represented by structural formula I: 其中,R1独立地选自烷基;R2独立地选自H原子;R3均独立地选自卤原子和烷基;X为N原子或CH。Wherein, R 1 is independently selected from an alkyl group; R 2 is independently selected from an H atom; R 3 is independently selected from a halogen atom and an alkyl group; X is an N atom or CH. 2、根据权利要求1所述的一种酰亚胺类化合物,其特征在于:所述结构式I表示的化合物选自:2. An imide compound according to claim 1, characterized in that: the compound represented by the structural formula I is selected from: N-(4,6-双甲基嘧啶-2-基)-1,2,3,4,5,6-六氢酞酰亚胺(I-1)N-(4,6-bismethylpyrimidin-2-yl)-1,2,3,4,5,6-hexahydrophthalimide (I-1) N-(4-氯-6-甲基嘧啶-2-基)-1,2,3,4,5,6-六氢酞酰亚胺(I-2)N-(4-chloro-6-methylpyrimidin-2-yl)-1,2,3,4,5,6-hexahydrophthalimide (I-2) N-(4-甲基嘧啶-2-基)-1,2,3,4,5,6-六氢酞酰亚胺(I-3)N-(4-methylpyrimidin-2-yl)-1,2,3,4,5,6-hexahydrophthalimide (I-3) N-(6-甲基吡啶-2-基)-1,2,3,4,5,6-六氢酞酰亚胺(I-4)。N-(6-methylpyridin-2-yl)-1,2,3,4,5,6-hexahydrophthalimide (I-4). 3、根据权利要求1所述的一种酰亚胺类化合物的制备方法,其特征在于:在惰性溶剂水、1,4-二氧六环、二氯甲烷、氯仿、四氢呋喃、甲苯、三甲苯中的单一溶剂或混合溶剂存在下,反应温度保持在80℃-150℃,将结构II所示的化合物与结构式III所示的化合物反应得到结构式I所示的化合物,3. The preparation method of a kind of imide compound according to claim 1, characterized in that: in the inert solvent water, 1,4-dioxane, dichloromethane, chloroform, tetrahydrofuran, toluene, trimethylbenzene In the presence of a single solvent or a mixed solvent, the reaction temperature is kept at 80°C-150°C, and the compound shown in the structure II is reacted with the compound shown in the structure formula III to obtain the compound shown in the structure formula I, 其中:R1独立地选自烷基;R2独立地选自H原子;R3均独立地选自卤原子和烷基;X为N原子或CH。Wherein: R 1 is independently selected from an alkyl group; R 2 is independently selected from an H atom; R 3 is independently selected from a halogen atom and an alkyl group; X is an N atom or CH. 4、根据权利要求1所述的一种酰亚胺类化合物的应用,其特征在于:在制备植物杀菌剂中的应用。4. The use of an imide compound according to claim 1, characterized in that it is used in the preparation of plant fungicides.
CNB2005100151680A 2005-09-23 2005-09-23 Hexahydro-phthalmide compound, its preparation and use thereof Expired - Lifetime CN1326849C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2005100151680A CN1326849C (en) 2005-09-23 2005-09-23 Hexahydro-phthalmide compound, its preparation and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2005100151680A CN1326849C (en) 2005-09-23 2005-09-23 Hexahydro-phthalmide compound, its preparation and use thereof

Publications (2)

Publication Number Publication Date
CN1746166A CN1746166A (en) 2006-03-15
CN1326849C true CN1326849C (en) 2007-07-18

Family

ID=36165908

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2005100151680A Expired - Lifetime CN1326849C (en) 2005-09-23 2005-09-23 Hexahydro-phthalmide compound, its preparation and use thereof

Country Status (1)

Country Link
CN (1) CN1326849C (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0152021A2 (en) * 1984-01-31 1985-08-21 Sankyo Company Limited Phthalimide derivatives, their preparation and their use as agricultural fungicides
WO1992000976A1 (en) * 1990-07-12 1992-01-23 Sankyo Company, Limited Pyridine derivative and selective herbicide
JPH0586028A (en) * 1991-10-03 1993-04-06 Sumitomo Chem Co Ltd N-phenyl amino acid ester derivative
US5393735A (en) * 1990-08-09 1995-02-28 Rohm And Haas Company Herbicidal glutarimides
EP0661282A1 (en) * 1993-12-22 1995-07-05 Basf Aktiengesellschaft Pyridine-2,3-dicarboxylic imides, process for their preparation and their use to control the growth of unwanted plants
EP0812842A2 (en) * 1996-06-10 1997-12-17 American Cyanamid Company Process for the preparation of 5-(alkoxymethyl)-2,3-pyridine-dicarboximide compounds

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0152021A2 (en) * 1984-01-31 1985-08-21 Sankyo Company Limited Phthalimide derivatives, their preparation and their use as agricultural fungicides
WO1992000976A1 (en) * 1990-07-12 1992-01-23 Sankyo Company, Limited Pyridine derivative and selective herbicide
US5393735A (en) * 1990-08-09 1995-02-28 Rohm And Haas Company Herbicidal glutarimides
JPH0586028A (en) * 1991-10-03 1993-04-06 Sumitomo Chem Co Ltd N-phenyl amino acid ester derivative
EP0661282A1 (en) * 1993-12-22 1995-07-05 Basf Aktiengesellschaft Pyridine-2,3-dicarboxylic imides, process for their preparation and their use to control the growth of unwanted plants
EP0812842A2 (en) * 1996-06-10 1997-12-17 American Cyanamid Company Process for the preparation of 5-(alkoxymethyl)-2,3-pyridine-dicarboximide compounds

Also Published As

Publication number Publication date
CN1746166A (en) 2006-03-15

Similar Documents

Publication Publication Date Title
CN101279219A (en) Double quaternary ammonium salt cationic surfactant and its preparation method and application
Swetha et al. Synthesis, characterization and antimicrobial evaluation of ferrocene–oxime ether benzyl 1 H-1, 2, 3-triazole hybrids
JPH02138238A (en) Benzylidene- and cinnamylidene-malononitrile derivative, preparation thereof and drug composition containing it as active ingredient and for suppressing proliferation in mammal cell
CN106916081B (en) The double acyloxyamides analog derivatives of a kind of amino, preparation method and applications
CN1326849C (en) Hexahydro-phthalmide compound, its preparation and use thereof
CN104098609B (en) Imidazo [2,1-b]-1,3,4-thiadiazoles containing ferrocene, preparation method and applications
CN106831635A (en) A kind of benzo oxygen azatropylidene class bacteriostatic agent and its synthetic method
Ghatole et al. Evaluation of substituted methyl cyclohexanone hybrids for anti-tubercular, anti-bacterial and anti-fungal activity: Facile syntheses under catalysis by ionic liquids
CN1321994C (en) 1,2,3,6-tetrahydro phthal-imide compound and their preparation and use
Prasad et al. Synthesis, Characterization and Biological Activity of Schiff Bases of Acetylacetone
CN112457322A (en) Insecticidal and antibacterial 5-imino substituted derivative and preparation method and application thereof
Ghabbour et al. Synthesis, crystal structure, density function theory, molecular docking and antimicrobial studies of 2-(3-(4-phenylpiperazin-1-yl) propyl) isoindoline-1, 3-dione
CN115417879B (en) N-pyrimidinyl cycloiminedibenzo [1,5] diazocine derivative and preparation and application thereof
CN112194667B (en) Substituted 1,4-benzoxazine diazepine compounds and preparation method and use thereof
CN1331863C (en) Imide analog compounds and its preparation method
US3711271A (en) Method for controlling algae
CN107602507B (en) Substituted formyl (morpholinylethyl) piperazine compound and application thereof
JP4016098B2 (en) Novel 1,3-selenazoline derivative and method for producing the same
CN119661540B (en) 13- (Benzothiazol-2-yl) -6, 12-cyclic imine dibenzo [ b, f ] [1,5] diazocine derivative, preparation and bactericidal activity thereof
CN116730947B (en) 2,4, 5-Trisubstituted thiazole compound and preparation method and application thereof
CN116730946B (en) 2-phenyl-4-methylthiazole compounds and preparation method and application thereof
CN111018848A (en) 1,3,5-Tri-substituted-4,5-dihydropyrazole derivatives and their application in pesticides
CN111004208B (en) 2-Cyano-3-thiophene-substituted valeramide derivatives and their applications
Riad et al. Reactions with acetoacetanilide: Synthesis and antibacterial activity of some new pyran, pyrano [2, 3-c] pyrazole and pyrano [2, 3-c]-pyridine derivatives
JP2616989B2 (en) 2,4-oxazolidinedione compound

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CX01 Expiry of patent term
CX01 Expiry of patent term

Granted publication date: 20070718